Related Experiment Video
Updated: Jan 24, 2026
10:49
Isolation and Purification of Murine Cardiac Pericytes
Published on: August 16, 2019
10.0K
Pericytes in Chronic Lung Disease.
Bushra Shammout1, Jill R Johnson2
1Biosciences Department, School of Life and Health Sciences, Aston University, Birmingham, UK.
Advances in Experimental Medicine and Biology
|June 1, 2019
Summary
Pericytes, crucial for blood vessel health, can transform into scar-forming cells during lung inflammation, hindering repair. Understanding this transition is key to developing new treatments for lung diseases.
Area of Science:
- Cell Biology
- Pulmonary Medicine
- Regenerative Medicine
Background:
- Pericytes are mesenchymal cells on microvessels, vital for homeostasis, leukocyte extravasation, and angiogenesis.
- A subset of pericytes exhibits progenitor cell functions, differentiating into osteocytes, chondrocytes, and adipocytes.
- Pericytes are implicated in acute and chronic lung pathologies, including ARDS, pulmonary hypertension, and fibrosis.
Purpose of the Study:
- To explore the dual role of pericytes in lung tissue, encompassing both regenerative potential and pathological transformation.
- To investigate the mechanisms driving pericyte-to-myofibroblast transition in pulmonary inflammation.
- To identify novel therapeutic targets for chronic lung diseases by understanding pericyte behavior.
Main Methods:
- Review of existing literature on pericyte biology and function in pulmonary contexts.
- Analysis of studies detailing pericyte differentiation and roles in acute and chronic lung diseases.
- Exploration of mechanisms underlying pericyte transformation into myofibroblasts.
Main Results:
- Pericytes possess regenerative capacity, differentiating into key cell types.
- In acute and chronic pulmonary inflammation, pericytes shift from repair to scar-forming myofibroblast roles.
- This transformation negatively impacts lung structure and function, contributing to disease progression.
Conclusions:
- Pericytes are critical players in lung pathologies, often promoting fibrosis rather than repair.
- Further research into pericyte-to-myofibroblast transition mechanisms is essential.
- Targeting pericyte behavior offers potential for novel therapeutic strategies in human pulmonary diseases.
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
01:25Chronic Kidney Disease I: Introduction
612
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
612
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
598
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
598
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K